companydata.dkcompanydata.dk

Fenucure Medical ApS: Financial statements 2023

CVR: 28486871

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Fenucure Medical ApS (CVR 28486871) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -911,893 and a net result of DKK -2,107,951 compared with DKK -3,548,690 the year before. Equity in the 2023 report amounted to DKK -1,675,755. The company had 2 employees in the financial year.

Gross Profit
DKK -911,893
Profit/Loss
DKK -2,107,951
Equity
DKK -1,675,755
Total Assets
DKK 1,467,795
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--912K-2.1M-1.7M2
2022--1.6M-3.5M-3.6M2
2021--1.7M-4.5M-2.5M2
2020--2.4M-3.2M-976K2
2018--608K-88K2.4M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Fenucure Medical ApS: The 2022 annual report is outJul 3, 2023

Fenucure Medical ApS has published its annual report for 2022. Gross profit came to DKK -1,590,483, and the net result was DKK -3,548,690.

About Fenucure Medical ApS

Fenucure Medical ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2005. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named V-BIOTEK ApS and VIND INVEST ApS. The management consists of Christian Hother Sørensen. The board consists of Nicolai Fink Gundersen (chair), Alex Gundersen, Mogens Viktor Madsen and Niels Christian Beck Vase. The company is owned by V-BIOTEK HOLDING ApS, Redwood Foundation ApS and Alex Gundersen Assens ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -1,214,608 and a net result of DKK -3,201,378 compared with DKK -1,529,007 the year before. Equity in the 2025 report amounted to DKK 593,861.

Source: annual report 2025, Danish Business Authority